Abbvie Inc (NYSE:ABBV) over-valued by 10%
| Website | https://www.abbvie.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $177,965,449,000 |
| Beta | 0.67286 |
| Average Volume | $8,158,093 |
| Last Dividend | 4.72% |
| Price on Aug 4, 2020 | $100.84 |
| Autochartist™ Valuation | $90.51 |
| Conclusion |
10% over-valued |
| Download Report |
